Acadian Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$230K Sell
2024
Q3
$304K Buy
2024
Q2
$167K Buy
2024
Q1
Sell
2023
Q4
$237K Buy
2023
Q3
Sell
2023
Q2
$177K Buy
2023
Q1
Sell
2022
Q4
$2.87M Sell
2022
Q3
$4.64M Buy
2022
Q2
$836K Sell
2022
Q1
$3.67M Buy
2019
Q2
Sell
2019
Q1
$333K Buy
2017
Q2
Sell
2017
Q1
$52K Buy